Elevated serum ferritin concentrations in prediabetic subjects

Background Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance,...

Full description

Saved in:
Bibliographic Details
Published inDiabetes & vascular disease research Vol. 5; no. 1; pp. 15 - 18
Main Authors Sharifi, Faranak, Nasab, N Mousavi, Zadeh, H Jazebi
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.03.2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance, in this study. Subjects & methods One hundred and eighty seven people, including 91 subjects with impaired fasting glucose (IFG) and 96 healthy people who were well matched for age and sex, were enrolled. Body mass index (BMI) and blood pressure of the participants were measured and serum cholesterol, triglyceride, white blood cells (WBC) count, C-reactive protein (CRP) and ferritin were evaluated. All the data were analysed by t-test, X 2 test and analysis of variance. Results The IFG group had higher serum ferritin concentrations (85.5±6.6 μg/L vs. 49.4±3.7 μg/L, p=0.001). A positive correlation was found between fasting plasma glucose and serum ferritin (r=0.29, p=0.001). Using multiple regression analysis, we found an association between serum ferritin and blood pressure (0.15, p=0.01), FPG (0.29, p=0.001), triglyceride (0.08, p=0.01) and cholesterol (0.07, p=0.03). The odds ratio for the association of IFG in male subjects with a high serum ferritin level was 8.3 (95% CI: 1.2–11.9, p=0.01) and for females was 3.06 (95% CI: 0.58–15, p=0.1). Conclusion Based on the data from our study, aelevation in serum ferritin can be seen in pre-diabetes stage, before the occurrence of an overt diabetes mellitus.
AbstractList Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance, in this study.BACKGROUNDFew data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance, in this study.One hundred and eighty seven people, including 91 subjects with impaired fasting glucose (IFG) and 96 healthy people who were well matched for age and sex, were enrolled. Body mass index (BMI) and blood pressure of the participants were measured and serum cholesterol, triglyceride, white blood cells (WBC) count, C-reactive protein (CRP) and ferritin were evaluated. All the data were analysed by t-test, chi2 test and analysis of variance.SUBJECTS & METHODSOne hundred and eighty seven people, including 91 subjects with impaired fasting glucose (IFG) and 96 healthy people who were well matched for age and sex, were enrolled. Body mass index (BMI) and blood pressure of the participants were measured and serum cholesterol, triglyceride, white blood cells (WBC) count, C-reactive protein (CRP) and ferritin were evaluated. All the data were analysed by t-test, chi2 test and analysis of variance.The IFG group had higher serum ferritin concentrations (85.5+/-6.6 microg/L vs. 49.4+/-3.7 microg/L, p=0.001). A positive correlation was found between fasting plasma glucose and serum ferritin (r=0.29, p=0.001). Using multiple regression analysis, we found an association between serum ferritin and blood pressure (0.15, p=0.01), FPG (0.29, p=0.001), triglyceride (0.08, p=0.01) and cholesterol (0.07, p=0.03). The odds ratio for the association of IFG in male subjects with a high serum ferritin level was 8.3 (95% CI: 1.2-11.9, p=0.01) and for females was 3.06 (95% CI: 0.58-15, p=0.1).RESULTSThe IFG group had higher serum ferritin concentrations (85.5+/-6.6 microg/L vs. 49.4+/-3.7 microg/L, p=0.001). A positive correlation was found between fasting plasma glucose and serum ferritin (r=0.29, p=0.001). Using multiple regression analysis, we found an association between serum ferritin and blood pressure (0.15, p=0.01), FPG (0.29, p=0.001), triglyceride (0.08, p=0.01) and cholesterol (0.07, p=0.03). The odds ratio for the association of IFG in male subjects with a high serum ferritin level was 8.3 (95% CI: 1.2-11.9, p=0.01) and for females was 3.06 (95% CI: 0.58-15, p=0.1).Based on the data from our study, aelevation in serum ferritin can be seen in pre-diabetes stage, before the occurrence of an overt diabetes mellitus.CONCLUSIONBased on the data from our study, aelevation in serum ferritin can be seen in pre-diabetes stage, before the occurrence of an overt diabetes mellitus.
Background Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance, in this study. Subjects & methods One hundred and eighty seven people, including 91 subjects with impaired fasting glucose (IFG) and 96 healthy people who were well matched for age and sex, were enrolled. Body mass index (BMI) and blood pressure of the participants were measured and serum cholesterol, triglyceride, white blood cells (WBC) count, C-reactive protein (CRP) and ferritin were evaluated. All the data were analysed by t-test, X 2 test and analysis of variance. Results The IFG group had higher serum ferritin concentrations (85.5±6.6 μg/L vs. 49.4±3.7 μg/L, p=0.001). A positive correlation was found between fasting plasma glucose and serum ferritin (r=0.29, p=0.001). Using multiple regression analysis, we found an association between serum ferritin and blood pressure (0.15, p=0.01), FPG (0.29, p=0.001), triglyceride (0.08, p=0.01) and cholesterol (0.07, p=0.03). The odds ratio for the association of IFG in male subjects with a high serum ferritin level was 8.3 (95% CI: 1.2–11.9, p=0.01) and for females was 3.06 (95% CI: 0.58–15, p=0.1). Conclusion Based on the data from our study, aelevation in serum ferritin can be seen in pre-diabetes stage, before the occurrence of an overt diabetes mellitus.
Background Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance, in this study. Subjects & methods One hundred and eighty seven people, including 91 subjects with impaired fasting glucose (IFG) and 96 healthy people who were well matched for age and sex, were enrolled. Body mass index (BMI) and blood pressure of the participants were measured and serum cholesterol, triglyceride, white blood cells (WBC) count, C-reactive protein (CRP) and ferritin were evaluated. All the data were analysed by t-test, X 2 test and analysis of variance. Results The IFG group had higher serum ferritin concentrations (85.5±6.6 μg/L vs. 49.4±3.7 μg/L, p=0.001). A positive correlation was found between fasting plasma glucose and serum ferritin (r=0.29, p=0.001). Using multiple regression analysis, we found an association between serum ferritin and blood pressure (0.15, p=0.01), FPG (0.29, p=0.001), triglyceride (0.08, p=0.01) and cholesterol (0.07, p=0.03). The odds ratio for the association of IFG in male subjects with a high serum ferritin level was 8.3 (95% CI: 1.2–11.9, p=0.01) and for females was 3.06 (95% CI: 0.58–15, p=0.1). Conclusion Based on the data from our study, aelevation in serum ferritin can be seen in pre-diabetes stage, before the occurrence of an overt diabetes mellitus.
Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the relationship between serum ferritin levels and impaired fasting glucose, a pre-diabetes stage associated with insulin resistance, in this study. One hundred and eighty seven people, including 91 subjects with impaired fasting glucose (IFG) and 96 healthy people who were well matched for age and sex, were enrolled. Body mass index (BMI) and blood pressure of the participants were measured and serum cholesterol, triglyceride, white blood cells (WBC) count, C-reactive protein (CRP) and ferritin were evaluated. All the data were analysed by t-test, chi2 test and analysis of variance. The IFG group had higher serum ferritin concentrations (85.5+/-6.6 microg/L vs. 49.4+/-3.7 microg/L, p=0.001). A positive correlation was found between fasting plasma glucose and serum ferritin (r=0.29, p=0.001). Using multiple regression analysis, we found an association between serum ferritin and blood pressure (0.15, p=0.01), FPG (0.29, p=0.001), triglyceride (0.08, p=0.01) and cholesterol (0.07, p=0.03). The odds ratio for the association of IFG in male subjects with a high serum ferritin level was 8.3 (95% CI: 1.2-11.9, p=0.01) and for females was 3.06 (95% CI: 0.58-15, p=0.1). Based on the data from our study, aelevation in serum ferritin can be seen in pre-diabetes stage, before the occurrence of an overt diabetes mellitus.
Author Nasab, N Mousavi
Sharifi, Faranak
Zadeh, H Jazebi
Author_xml – sequence: 1
  givenname: Faranak
  surname: Sharifi
  fullname: Sharifi, Faranak
  organization: Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran
– sequence: 2
  givenname: N Mousavi
  surname: Nasab
  fullname: Nasab, N Mousavi
  organization: Division of Statistical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran
– sequence: 3
  givenname: H Jazebi
  surname: Zadeh
  fullname: Zadeh, H Jazebi
  organization: Department of Internal Medicine, Vali-e-asr Hospital, Zanjan, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18398807$$D View this record in MEDLINE/PubMed
BookMark eNp1kE1LxDAQhoOsuB969Co9eRC6Jk3aTi-CLOsHLHjRc0jTqWTppmuSLvjvzborguBcZhieGXifKRnZ3iIhl4zOOePZbbNr3DyjFOaU8hMyYWWepVCBGMVZlFXKCsHGZOr9mtK8KHM4I2MGvAKg5YTcLTvcqYBN4tENm6RF50wwNtG91WiDU8H01idxs3XYGFVjMDrxQ71GHfw5OW1V5_Hi2Gfk7WH5unhKVy-Pz4v7VaoFZyFVFDRmAilFUYkGOAhQRdUybFXBqjznRQt1CxQ45rSJVSjIszLTUAuOgs_I9eHv1vUfA_ogN8Zr7DplsR-8LKmoIMaN4NURHOoNNnLrzEa5T_mTOALpAdCu995h-4tQuTcq90bl3qiMRiPP__DahG8p0Y3p_r26OVx59Y5y3Q_ORj3_wF_TsIfp
CitedBy_id crossref_primary_10_1002_dmrr_973
crossref_primary_10_1111_dme_12343
crossref_primary_10_3390_ijerph110201647
crossref_primary_10_1530_EJE_13_0145
crossref_primary_10_29252_ijrm_15_3_155
crossref_primary_10_22159_ijcpr_2022v14i1_44108
crossref_primary_10_1016_j_cmet_2013_02_007
crossref_primary_10_2337_db13_1195
crossref_primary_10_1186_s13023_021_02020_y
crossref_primary_10_3109_09637480903555150
crossref_primary_10_1016_j_bbagen_2024_130713
crossref_primary_10_1016_j_diabres_2018_03_001
crossref_primary_10_3390_nu15081935
crossref_primary_10_4103_ejim_ejim_100_19
crossref_primary_10_3892_etm_2014_1668
crossref_primary_10_1155_jdr_8835829
crossref_primary_10_1016_j_jdiacomp_2021_107977
crossref_primary_10_1016_j_metabol_2010_03_007
crossref_primary_10_4254_wjh_v7_i9_1192
crossref_primary_10_1016_j_diabet_2016_07_028
crossref_primary_10_3945_ajcn_111_015743
crossref_primary_10_3390_metabo11120871
crossref_primary_10_1007_s12011_015_0384_6
crossref_primary_10_1007_s00204_010_0577_x
crossref_primary_10_1152_ajpendo_00022_2010
crossref_primary_10_1007_s13410_015_0308_1
crossref_primary_10_4236_jdm_2014_43034
crossref_primary_10_1016_j_dsx_2013_02_004
crossref_primary_10_1172_JCI44421
crossref_primary_10_1016_j_orcp_2013_01_003
crossref_primary_10_1111_j_1753_0407_2010_00100_x
crossref_primary_10_1007_s11892_014_0488_y
crossref_primary_10_1186_2251_6581_13_16
crossref_primary_10_3390_biom11111589
Cites_doi 10.2337/diabetes.51.8.2348
10.1136/bmj.320.7251.1706
10.1079/BJN2001421
10.1006/bbrc.1998.9326
10.2337/diacare.24.7.1187
10.2337/diacare.20.3.426
10.1055/s-2002-33071
10.1146/annurev.med.53.082901.103904
10.1024/0300-9831.70.3.119
10.2337/diacare.22.12.1978
10.1136/bmj.317.7160.727
10.2337/diacare.27.2.622
10.2337/diabetes.51.4.1000
10.1016/S0140-6736(00)02397-7
10.1385/ENDO:24:2:111
10.7326/0003-4819-139-10-200311180-00029
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.3132/dvdr.2008.003
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1752-8984
EndPage 18
ExternalDocumentID 18398807
10_3132_dvdr_2008_003
10.3132_dvdr.2008.003
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-TM
01A
0R~
2WC
4.4
53G
54M
5VS
AABMB
AADUE
AAJPV
AARDL
AARIX
AASGM
ABAWP
ABCCA
ABEIX
ABFWQ
ABJIS
ABKRH
ABQXT
ABRHV
ABVFX
ABXGC
ACARO
ACDSZ
ACDXX
ACGFS
ACOFE
ACROE
ADBBV
ADOGD
ADPDF
ADZZY
AENEX
AEQLS
AERKM
AEUHG
AEWDL
AEXNY
AFCOW
AFEET
AFKRG
AFRWT
AFUIA
AGNHF
AHJOV
AJUZI
ALMA_UNASSIGNED_HOLDINGS
ARTOV
AUTPY
AYAKG
B8M
BAWUL
BDDNI
BKSCU
BSEHC
CAG
CDWPY
CFDXU
COF
DC-
DC.
DOPDO
DU5
EBS
EJD
EMOBN
F5P
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HZ~
J8X
K.F
N9A
O9-
OK1
OVD
OVEED
P.9
P.B
P2P
PGMZT
ROL
RPM
S01
SAUOL
SCDPB
SCNPE
SFC
TEORI
TR2
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
ACHEB
CITATION
CGR
CUY
CVF
ECM
EIF
M4V
NPM
7X8
ID FETCH-LOGICAL-c431t-a08ce24e00e494d83848a69f1efa6195536f8bf8083e50dddd6a85272c8b43e43
IEDL.DBID AFRWT
ISSN 1479-1641
IngestDate Fri Jul 11 07:24:08 EDT 2025
Thu Apr 03 07:04:30 EDT 2025
Tue Jul 01 05:26:35 EDT 2025
Thu Apr 24 22:53:41 EDT 2025
Tue Jun 17 22:52:30 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords ferritin
pre-diabetes
fasting plasma glucose
insulin resistance
Language English
License https://journals.sagepub.com/page/policies/text-and-data-mining-license
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c431t-a08ce24e00e494d83848a69f1efa6195536f8bf8083e50dddd6a85272c8b43e43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://journals.sagepub.com/doi/pdf/10.3132/dvdr.2008.003
PMID 18398807
PQID 70498147
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_70498147
pubmed_primary_18398807
crossref_primary_10_3132_dvdr_2008_003
crossref_citationtrail_10_3132_dvdr_2008_003
sage_journals_10_3132_dvdr_2008_003
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-03-01
PublicationDateYYYYMMDD 2008-03-01
PublicationDate_xml – month: 03
  year: 2008
  text: 2008-03-01
  day: 01
PublicationDecade 2000
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: England
PublicationTitle Diabetes & vascular disease research
PublicationTitleAlternate Diab Vasc Dis Res
PublicationYear 2008
Publisher SAGE Publications
Publisher_xml – name: SAGE Publications
References Salonen JT, Tuomainen TP, Kontula K 2000; 24
Salonen JT, Tuomainen TP, Nyyssonen K, Lakka HM, Punnonen K 1998; 317
Ferrannini E 2000; 355
Ford ES, Cogswell ME 1999; 22
Sharifi F, Sazandeh SH 2004; 42
Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Hernandez-Aguado I, Ricart W 2002; 51
Ren Y, Tian H, Liang J, Zhao G 2004; 27
Tuomainen TP, Nyyssonen K, Salonen R 1997; 20
Haap M, Fristsche A, Mensing HJ, Haring H-U, Stumvoll M 2003; 139
Fernandez-Real JM, Lopez-Bermejo A, Ricart W 2002; 51
Resnick HE, Howard BV 2002; 53
Qian M, Liu M, Eaton JW 1998; 250
Moczulski DK, Grzeszczak W, Gawlik B 2001; 24
Oliva R, Navials A, Sanchez M 2004; 24
Hua NW, Stoohs RA, Facchini FS 2001; 86
Kankora K, Jansen EH, Marova I 2002; 110
Kato I, Dnistrian AM, Schwartz M 2000; 70
atypb9
atypb8
Sharifi F (atypb3) 2004; 42
atypb15
atypb16
atypb17
atypb11
atypb12
atypb13
atypb14
atypb1
atypb2
atypb10
atypb5
atypb4
atypb7
atypb6
References_xml – volume: 51
  start-page: 1000
  year: 2002
  end-page: 04
  article-title: Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function
  publication-title: Diabetes
– volume: 42
  start-page: 142
  year: 2004
  end-page: 5
  article-title: Serum ferritin in type 2 diabetes mellitus and its relationship with HbA1c
  publication-title: Acta Medica Iranica
– volume: 53
  start-page: 245
  year: 2002
  end-page: 67
  article-title: Diabetes and cardiovascular disease
  publication-title: Annu Rev Med
– volume: 110
  start-page: 223
  year: 2002
  end-page: 9
  article-title: Relations among serum ferritin, C282Y and H63D mutations in the HFE gene in type 2 diabetes in the Czech population
  publication-title: Exp Clin Endocrinol Diabetes
– volume: 24
  start-page: 1706
  year: 2000
  end-page: 07
  article-title: Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study
  publication-title: BMJ
– volume: 51
  start-page: 2348
  year: 2002
  end-page: 54
  article-title: Cross-talk between iron metabolism and diabetes
  publication-title: Diabetes
– volume: 22
  start-page: 1978
  year: 1999
  end-page: 83
  article-title: Diabetes and serum ferritin concentration among US adults
  publication-title: Diabetes Care
– volume: 86
  start-page: 515
  year: 2001
  end-page: 19
  article-title: Low iron status and enhanced insulin sensitivity in lacto-ovo vegetarians
  publication-title: Br J Nutr
– volume: 20
  start-page: 426
  year: 1997
  end-page: 8
  article-title: Body iron stores are associated with serum insulin and blood glucose concentration: population study in 1, 013 eastern Finnish men
  publication-title: Diabetes Care
– volume: 250
  start-page: 385
  year: 1998
  end-page: 9
  article-title: Transition metals bind to glycated proteins forming redox active “glycochelates”: implications for the pathogenesis of certain diabetic complications
  publication-title: Biochem Biophys Res Commun
– volume: 70
  start-page: 119
  year: 2000
  end-page: 25
  article-title: Risk of iron overload among middle-aged women
  publication-title: Int J Vitam Res
– volume: 27
  start-page: 622
  year: 2004
  end-page: 3
  article-title: Elevated serum ferritin concentration in a glucose impaired population and in normal glucose tolerance first degree relatives in familial type 2 diabetic pedigrees
  publication-title: Diabetes Care
– volume: 24
  start-page: 1187
  year: 2001
  end-page: 91
  article-title: Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy
  publication-title: Diabetes Care
– volume: 24
  start-page: 111
  year: 2004
  end-page: 14
  article-title: The HFE gene is associated to an earlier onset and to the presence of diabetic nephropathy in diabetes mellitus type 2
  publication-title: Endocrine
– volume: 139
  start-page: 869
  year: 2003
  end-page: 71
  article-title: Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people
  publication-title: Ann Int Med
– volume: 317
  start-page: 727
  year: 1998
  end-page: 30
  article-title: Relation between iron stores and non-insulin dependent diabetes in men: case-control study
  publication-title: BMJ
– volume: 355
  start-page: 2181
  year: 2000
  end-page: 2
  article-title: Insulin resistance, iron, and the liver
  publication-title: Lancet
– ident: atypb12
  doi: 10.2337/diabetes.51.8.2348
– ident: atypb14
  doi: 10.1136/bmj.320.7251.1706
– ident: atypb16
  doi: 10.1079/BJN2001421
– ident: atypb10
  doi: 10.1006/bbrc.1998.9326
– ident: atypb13
  doi: 10.2337/diacare.24.7.1187
– ident: atypb1
  doi: 10.2337/diacare.20.3.426
– ident: atypb7
  doi: 10.1055/s-2002-33071
– ident: atypb15
  doi: 10.1146/annurev.med.53.082901.103904
– ident: atypb17
  doi: 10.1024/0300-9831.70.3.119
– ident: atypb2
  doi: 10.2337/diacare.22.12.1978
– ident: atypb4
  doi: 10.1136/bmj.317.7160.727
– ident: atypb5
  doi: 10.2337/diacare.27.2.622
– ident: atypb9
  doi: 10.2337/diabetes.51.4.1000
– ident: atypb11
  doi: 10.1016/S0140-6736(00)02397-7
– volume: 42
  start-page: 142
  year: 2004
  ident: atypb3
  publication-title: Acta Medica Iranica
– ident: atypb8
  doi: 10.1385/ENDO:24:2:111
– ident: atypb6
  doi: 10.7326/0003-4819-139-10-200311180-00029
SSID ssj0056758
Score 1.9482085
Snippet Background Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We...
Few data are available on the association of variables of the insulin resistance syndrome and serum ferritin, an indicator of body iron stores. We examined the...
SourceID proquest
pubmed
crossref
sage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 15
SubjectTerms Adult
Blood Glucose
Diabetes Mellitus, Type 2 - prevention & control
Female
Ferritins - blood
Glucose Tolerance Test
Humans
Insulin Resistance
Male
Middle Aged
Prediabetic State - blood
Regression Analysis
Title Elevated serum ferritin concentrations in prediabetic subjects
URI https://journals.sagepub.com/doi/full/10.3132/dvdr.2008.003
https://www.ncbi.nlm.nih.gov/pubmed/18398807
https://www.proquest.com/docview/70498147
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZS8QwEB50BfFFvF3PguKT0W6bJumLIrqLCCqI11tpkxQW3SrbVvDfO9NDERXsS2kamjKZTL45A7AbGuEqHWsmtXQZVz3OwlAmTBophMZHqatoiytxfscvHoPHCXhqc2EaCuYHFFaFf1QJa1rdZI0-rHRM3zs0b2bcxkH6x2UximpTd3uiBrWQb7ockVtbUzDkO2tT2yZhypMi8DowdTK4ebhtBXdA2LlKRpIhQy2iV5fk_Dng9y3sBy79FhNWbVODOZht8KVzUjPEPEzYbAGmLxsP-iIc9Z_tG-JL4yDvlSMnpcqMxTBzNOUvZk0R3dzBltexrS2zQ-3kZUIGm3wJ7gb929Nz1pyhwDRCg4LFOBPW49Z1LQ-5Ub7iKhZh2rNpjLpTEPgiVUmqEInZwDV4iVgFnvS0Srhvub8Mnewls6vg9AyuVo-bhJxxIkEhb8kJyQW5bkUqurDfkiXSTYFxOufiOUJFg6gYERWbcy9dvwt7n91f68oaf3XcbmkcIe-TQyPO7EuZRxLVG2KnLqzUpP_6EOI-lEz4ZofmImrZ6vcR1v7Vax1m6mARCkDbgE4xLu0mIpIi2Wo4Ce_X9_3-2QcNHt-n
linkProvider SAGE Publications
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dT8IwEL8gJOqL8Vv8YonGJ6cb69ruxYQYCCrwYCDytmxtl5DgIAz4-72yTkPQxL1tu3TLr9fr73rXK8BtIKnDRSRsJphjE-4SOwhYbDPJKBV4y8Qq26JH2wPyOvSHJaDFXhiDYPag06rwj1bG2oxuXWXwUS7lrEiB9LagQny0wmWoNFrvH_3CBvuaBq_2FbHARofAzatrbjawPhttUMy19K7VjNPahz1DFa1G3rcHUFLpIWx3TTD8CJ6aY7VEqigtVKPFp5XoIovzUWoJvRUxNfVwMwufTGcqX2QdCStbxHrtJTuGQavZf27b5jgEW-AsP7cjBFXViXIcRQIiuccJj2iQuCqJ0A3yfY8mPE44kirlOxIvGnG_zuqCx8RTxDuBcjpJ1RlYrsSBVycy1nE1GqO9VjqeSKiOwtKEVuG-gCUUpla4PrJiHKLPoFEMNYrmCEvHq8Ldt_g0L5Lxl2CtwDhENdaxiShVk0UWMvRUtGZU4TSH_qchpHBoZPDNje6LsNCQ379w_i-pGuy0-91O2HnpvV3Abp4DovPKLqE8ny3UFRKNeXxttOoLeWLLcQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwED90wvBF_HZ-raD4ZLVr0yR9EUQdfiOyoW-lTVIYaB3rtr_fuzZVhgr2re2Rlsvl8rvcLxeAw0hzT6pEuUIJz2Wyw9woEqkrtOBc4a1QJdvikV_32e1r-GpZlbQXxmqwOCFaFf5R6axpdA91dlqGmIF_qqd6VNMgg3lYYAwDvAYsnHefX3q1Hw4JCpd7i0TkYlDQqSps_mxgdkb6ATNnKF7lrNNdhiULF53zqn9XYM7kq9B8sAnxNTi7ejNThIvaQVOavDsZFVocD3JH0XbE3NbELRx8MhyZaqF1oJxiktL6S7EO_e5V7-LatUciuApn-rGboGKNz4znGRYxLQPJZMKjrGOyBEOhMAx4JtNMIrAyoafx4okMfeErmbLAsGADGvlHbrbA6WgcfD7TKeXWeIo-21BOkXHKxPKMt-C4VkusbL1wOrbiLca4gbQYkxbtMZZe0IKjL_FhVSjjL8F2reMYTZnyE0luPiZFLDBaIetowWal-u-GEMaho8E3B9QXcW0lv39h-19SbWg-XXbj-5vHux1YrGggRC3bhcZ4NDF7iDXG6b41qk-qIsyK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+serum+ferritin+concentrations+in+prediabetic+subjects&rft.jtitle=Diabetes+%26+vascular+disease+research&rft.au=Sharifi%2C+Faranak&rft.au=Nasab%2C+N+Mousavi&rft.au=Zadeh%2C+H+Jazebi&rft.date=2008-03-01&rft.issn=1479-1641&rft.volume=5&rft.issue=1&rft.spage=15&rft_id=info:doi/10.3132%2Fdvdr.2008.003&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-1641&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-1641&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-1641&client=summon